ONC BeOne Medicines

• None no insider bought on the open market
• $16.5M sold by 11 insiders outside a trading plan
• $375M sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Xiaodong Wang Director
   Planned sale
   $11.3M 31,028 shares at $362.97 100% of stake
   Traded Oct 27 Filed Oct 29
   ↗
3. Xiaodong Wang Director
   Planned sale
   $10.9M 31,027 shares at $350.99 100% of stake
   Traded Oct 13 Filed Oct 15
   ↗
4. Chan Henry Lee SVP, General Counsel
   Planned sale
   $418K 1,115 shares at $375.00 100% of stake
   Traded Sep 30 Filed Oct 2
   ↗
5. Xiaodong Wang Director
   Planned sale
   $11.3M 31,028 shares at $364.79 100% of stake
   Traded Sep 28 Filed Sep 30
   ↗
6. Xiaodong Wang Director
   Planned sale
   $13.4M 38,287 shares at $349.10 100% of stake
   Traded Sep 8 Filed Sep 10
   ↗
7. Titus B. Ball Principal Accounting Officer
   Sale
   $47K 132 shares at $355.86 100% of stake
   Traded Sep 1 Filed Sep 3
   ↗
8. Xiaobin Wu COO
   Planned sale
   $106K 280 shares at $380.00 100% of stake
   Traded Aug 25 Filed Aug 27
   ↗
9. Chan Henry Lee SVP, General Counsel
   Planned sale
   $960K 2,666 shares at $360.00 100% of stake
   Traded Aug 11 Filed Aug 13
   ↗
10. John Oyler CEO
    Planned sale
    $86.5M 240,810 shares at $359.12 100% of stake
    Traded Aug 10–12 Filed Aug 12
    ↗
11. Aaron Rosenberg CFO
    Sale
    $362K 1,157 shares at $312.72 100% of stake
    Traded Aug 3 Filed Aug 5
    ↗
12. Chan Henry Lee SVP, General Counsel
    Sale
    $338K 1,044 shares at $323.69 100% of stake
    Traded Jul 30 Filed Aug 3
    ↗
13. Chan Henry Lee SVP, General Counsel
    Planned sale
    $542K 1,669 shares at $325.00 100% of stake
    Traded Jul 22 Filed Jul 24
    ↗
14. John Oyler CEO
    Planned sale
    $34.6M 109,713 shares at $315.28 100% of stake
    Traded Jul 20–21 Filed Jul 22
    ↗
15. John Oyler CEO
    Planned sale
    $20.2M 64,628 shares at $312.00 100% of stake
    Traded Jul 17 Filed Jul 17
    ↗
16. John Oyler CEO
    Planned sale
    $89.4M 283,154 shares at $315.56 100% of stake
    Traded Jul 15–16 Filed Jul 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 51 option exercises, 27 stock grants, and 3 gifts.